CN Patent
CN105838714B — 反义分子和治疗疾病的方法
Assigned to University of Western Australia · Expires 2020-07-17 · 6y expired
What this patent protects
一种能在肌营养不良蛋白基因中结合所选靶点诱导外显子跳跃的反义分子,如下序列所述,SEQ ID NO:1至59。
USPTO Abstract
一种能在肌营养不良蛋白基因中结合所选靶点诱导外显子跳跃的反义分子,如下序列所述,SEQ ID NO:1至59。
Drugs covered by this patent
- Amondys 45 (CASIMERSEN) · Sarepta
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.